Hasil Pencarian - Siqing Fu

Perbaiki Hasil
  1. 1
    Wilms’ Tumor 1 (WT1): The Vaccine for Cancer

    Wilms’ Tumor 1 (WT1): The Vaccine for Cancer oleh Kyaw Zaw Hein, Shuyang Yao, Siqing Fu

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies

    Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies oleh Kyaw Z. Hein, Bettzy Stephen, Siqing Fu

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Spreading of Alu methylation to the promoter of the MLH1 gene in gastrointestinal cancer.

    Spreading of Alu methylation to the promoter of the MLH1 gene in gastrointestinal cancer. oleh Xiyin Wang, Jing Fan, Dong Liu, Siqing Fu, Sigurdur Ingvarsson, Huiping Chen

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas

    295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas oleh Hui Zhou, Ying Liu, Fang Liu, Siqing Fu, Nehal Lakhani, Marlana Orloff, Kedan Lin, Shuling Yan

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

    Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab oleh Siqing Fu, Sang T. Kim, Jean Tayar, David S. Hong, Elliot Norry, Amy Sun, Danxia Ke, Juli Miller

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    383 First-in-man clinical trial of intratumoral injection of clostridium Novyi-NT spores in combination with pembrolizumab in patients with treatment-refractory advanced solid tumors

    383 First-in-man clinical trial of intratumoral injection of clostridium Novyi-NT spores in combination with pembrolizumab in patients with treatment-refractory advanced solid tumo... oleh Siqing Fu, Daniel Karp, Maura Gillison, Anjali Raina, Brent Kreider, David Tung, Mary Varterasian, Khashayarsha Khazaie

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance

    Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance oleh Anas Alshawa, Jing Gong, Valerie Marcott, Rabia Khan, Valentine Boving, Lakeshia Brown, Jeff Beno, Ed Kheder, Siqing Fu

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. oleh Filip Janku, J Jack Lee, Apostolia M Tsimberidou, David S Hong, Aung Naing, Gerald S Falchook, Siqing Fu, Rajyalakshmi Luthra, Ignacio Garrido-Laguna, Razelle Kurzrock

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. oleh Ignacio Garrido-Laguna, David S Hong, Filip Janku, Ly M Nguyen, Gerald S Falchook, Siqing Fu, Jenifer J Wheler, Rajyalakshmi Luthra, Aung Naing, Xuemei Wang, Razelle Kurzrock

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    732 Immune activation with plinabulin enhances anti-tumor response combining radiation with immune checkpoint blockade

    732 Immune activation with plinabulin enhances anti-tumor response combining radiation with immune checkpoint blockade oleh Vivek Subbiah, Huiying Sun, Siqing Fu, Lan Huang, Hui Gao, Steven H Lin, Ziyi Li, Evan Cohen, James Reuben, June Lu, Ken Lloyd, James Tonra

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    489 TWT-101: a phase 1 study of the novel HPK1 inhibitor CFI-402411 in patients with advanced cancer

    489 TWT-101: a phase 1 study of the novel HPK1 inhibitor CFI-402411 in patients with advanced cancer oleh Judy Wang, Omid Hamid, Siqing Fu, Johanna Bendell, Anna Spreafico, Alexander Spira, Kyriakos Papadopoulos, Brigette Ma, Mark Bray, Graham Fletcher, Glenn Michelson, Emily Roberts-Thomson

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors

    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors oleh Shuyang Yao, Filip Janku, Kimberly Koenig, Apostolia Maria Tsimberidou, Sarina Anne Piha‐Paul, Nai Shi, John Stewart, Amanda Johnston, John Bomalaski, Funda Meric‐Bernstam, Siqing Fu

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (TN-Mel)

    797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (T... oleh Joseph Markowitz, Siqing Fu, Gregory Daniels, Lyudmila Bazhenova, Nikhil Khushalani, Zeynep Eroglu, Andrew Brohl, Heather Yeckes-Rodin, Lori McCormick, Michael Kurman, Mireille Gillings, Gloria Lee

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist

    8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist oleh Heather Lin, Fei Yang, Siqing Fu, Joud Hajjar, Daniel Karp, Bettzy Stephen, Ignacio Wistuba, Yeonjoo Choi, Cheuk Hong Leung, Jordi Rodon, Edwin Parra, Naval Daver, Yali Yang

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials oleh Roman Groisberg, David S. Hong, Amini Behrang, Kenneth Hess, Filip Janku, Sarina Piha-Paul, Aung Naing, Siqing Fu, Robert Benjamin, Shreyaskumar Patel, Neeta Somaiah, Anthony Conley, Funda Meric-Bernstam, Vivek Subbiah

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors

    Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors oleh Niamh Coleman, Bettzy Stephen, Siqing Fu, Daniel Karp, Vivek Subbiah, Jordi Rodon Ahnert, Sarina A. Piha‐Paul, John Wright, Senait N. Fessahaye, Fengying Ouyang, Bulent Yilmaz, Funda Meric‐Bernstam, Aung Naing

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies

    A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies oleh Siqing Fu, David E. Piccioni, Hongtao Liu, Rimas V. Lukas, Santosh Kesari, Dawit Aregawi, David S. Hong, Kenichiro Yamaguchi, Kate Whicher, Yi Zhang, Yu-Luan Chen, Nagaraju Poola, John Eddy, David Blum

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine

    Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine oleh Apostolia-Maria Tsimberidou, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Filip Janku, Aung Naing, Siqing Fu, Sarina Piha-Paul, Carrie Cartwright, Russell R. Broaddus, Graciela M. Nogueras Gonzalez, Patrick Hwu, Razelle Kurzrock

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial

    Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial oleh Vivek Subbiah, Ecaterina Ileana Dumbrava, Yunfang Jiang, Kyaw Z. Thein, Aung Naing, David S. Hong, Siqing Fu, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Filip Janku, Funda Meric-Bernstam, Razelle Kurzrock, Gerald Falchook

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

    Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells oleh Yanfang Li, Tao Liu, Cristina Ivan, Cristina Ivan, Jie Huang, De-Yu Shen, John J. Kavanagh, Robert C. Bast, Siqing Fu, Wei Hu, Anil K. Sood, Anil K. Sood, Anil K. Sood

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: